#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
00:00
The Eradicate Trial for Staff Arias Bacteremia
This is Ceph de Bipril compared to Daptomycin with or without optional as tree name for the treatment of complicated staff, Arias Bacteremia. This was presented by none other than Dr. Tom Holland, who's an associate professor in the division of ID at Duke University Medical Center. Unlike the last trial that got dapedo, it's approval in 2006. And I don't know about y'all, but when I started doing this math, I think I was in junior high when that happened.
Transcript
Play full episode
